Glucagon-like peptide-1 receptor agonists in neoplastic diseases

Glucagon-like peptide-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent for the treatment of type 2 diabetes, has well-known effects such as lowering blood sugar, ameliorating inflammation, reducing weight, and lowering blood lipids. It has also been shown that it can influence the proliferat...

Full description

Bibliographic Details
Published in:Frontiers in Endocrinology
Main Authors: Lisan Ji, Xianzhen He, Xinwen Min, Handong Yang, Wenwen Wu, Hao Xu, Jun Chen, Aihua Mei
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Subjects:
GLP-1RA
tumor diseases
function
mechanism
agonists
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1465881/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1465881/full

Similar Items